Based on the pan-cancer analysis of drug sensitivity datasets, ADM and ADM2 expression levels were significantly correlated with sensitivity of various medications in both the GDSC and CTRP databases, with ADM showing a broader and more significant correlation. This evidence concerns the gene ADM2 and cancer.